Purple Innovation, Inc. (PRPL): Nasdaq/NYSE listing notice — Purple Innovation receives Nasdaq delisting determination; will appeal by May 12

Purple Innovation, Inc.

Nasdaq notified Purple on May 5, 2026 that it failed to regain compliance with the $1.00 minimum bid price rule.
Cure period ended May 4, 2026; company not eligible for a second 180-day period.
Delisting scheduled for May 14, 2026 unless appeal is requested by May 12, 2026.
Company plans to appeal and request a hearing before the Nasdaq Hearings Panel.
Expects stock to trade pending hearing; plans to effect a reverse stock split to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Purple Innovation, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

May 5, 2026, Purple Innovation, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as notified by Nasdaq on November 5, 2025, the bid price of the Company’s Class A common stock had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until May 4, 2026, to regain compliance with the

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Purple Innovation, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-054487

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.